Izrael - hebrejština - Ministry of Health

teva medical marketing ltd. - sodium chloride - תמיסה לאינפוזיה - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.

Izrael - hebrejština - Ministry of Health

teva medical marketing ltd. - sodium chloride - תמיסה לאינפוזיה - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.

Izrael - hebrejština - Ministry of Health

bio-med - j.r ltd, israel - levosimendan - תרכיז להכנת תמיסה לאינפוזיה - levosimendan 2.5 mg/ml - levosimendan - levosimendan - therapeutic indications: short-term treatment of acutely decompensated severe chronic heart failure.simdax should only be used as add-on therapy in situations where conventional therapy with e.g. diuretics, ace-inhibitors and digitalis is not sufficient and where there is a need for inotropic support.

Izrael - hebrejština - Ministry of Health

unipharm ltd, israel - bisoprolol fumarate - טבליה - bisoprolol fumarate 5 mg - bisoprolol - bisoprolol - management of angina pectoris, hypertention. treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ace inhibitors and diuretics, and optionally cardiac glycosides.

Izrael - hebrejština - Ministry of Health

unipharm ltd, israel - bisoprolol hemifumarate - טבליה - bisoprolol hemifumarate 2.5 mg - bisoprolol - bisoprolol - treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ace inhibitors and diuretics, and optionally cardiac glycosides.

Izrael - hebrejština - Ministry of Health

unipharm ltd, israel - bisoprolol hemifumarate - טבליות מצופות פילם - bisoprolol hemifumarate 1.25 mg - bisoprolol - bisoprolol - treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function (ejection fraction < 35%, determined by echocardiography) in addition to ace inhibitors and diuretics, and optionally cardiac glycosides

Izrael - hebrejština - Ministry of Health

merck sharp & dohme israel ltd - lisinopril as dihydrate 10 mg - tablets - lisinopril - hypertension: tensopril is indicated for the treatment of essentioal hypertension and renovascular hypertension. tensopril may be used alone as initial therapy or concomitantly with other classes of antihypertensive agents. congestive heart failure: tensopril is indicated as adjunctive therapy in the management of heart failure in patients who are not responding adequately to diuretics and digitalis. acute myorardial infarction: tensopril is indicated for the treatment of hemodynamically stable patients within 24 hours of acute myocardial infarction to improve survival.

Izrael - hebrejština - Ministry of Health

merck sharp & dohme israel ltd - lisinopril as dihydrate 20 mg - tablets - lisinopril - hypertension: tensopril is indicated for the treatment of essential hypertension and renovascular hypertension. tensopril may be used alone as initial therapy or concomitantly with other classes of antihypertensive agents. congestive heart failure: tensopril is indicated as adjunctive therapy in the management of heart failure in patients who are not responding adequately to diuretics and digitalis. acute myocardial infarction: tensopril is indicated for the treatment of hemodynamically stable patients within 24 hous of acute myocardial infarction to improve survival.

Izrael - hebrejština - Ministry of Health

merck sharp & dohme israel ltd - lisinopril as dehydrate 5 mg - tablets - lisinopril - hypertension: tensopril is indicated for the treatment of essential hypertension and renovascular hypertension.tensopril may be used alone as initial therapy, or concomitantly with other classes of antihypertensive agents. congestive heart failure: tensopril is indicated as adjunctive therapy in the management of heart failure in patients who are not responding adequately to diuretics and digitalis. acute myocardial infarction: tensopril is indicated for the treatment of hemodynamically stable patients within 24 hours of acute myocardial infarction to improve survival.

Izrael - hebrejština - Ministry of Health

teva pharmaceutical industries ltd, israel - losartan potassium - טבליות מצופות פילם - losartan potassium 50 mg - losartan - losartan - hypertension: losartan is indicated for the treatment of heart failure (nyha ii and iii) usually in addition to diuretics and/or digitalis if use of an ace inhibitor is not appropriate. switching patients with heart failure who are stable on an ace inhibitor to losartan is not recommended. renal protection in type-2 diabetic patients with proteinuria: losartan is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine end stage renal disease (need for dialysis or renal transplantation) or death and to reduce proteinuria. reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. losartan is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death stroke and myocardial infarction in hypertensive patients with left ventricular hypertrophy. the benefit of losartan on the primary deposite endpoi